Document:

Exhibit

Exhibit 10.1
SUMMARY OF DIRECTOR AND NAMED EXECUTIVE OFFICER COMPENSATION
This summary sets forth the compensation of the Directors of Kimball Electronics, Inc. (the “Company”).  The summary also includes compensation of the Company’s current Chief Executive Officer, Chief Financial Officer, and the three other most highly compensated executive officers, who will be referred to herein as our “Named Executive Officers.”
Director Compensation
All Non-Employee Directors receive annual retainer fees of $75,000 plus an additional $40,000 of retainer fees paid in shares of Common Stock of the Company for service as Directors.  The Lead Independent Director of the Board of Directors, the Chairperson of the Audit Committee of the Board of Directors, and the Chairperson of the Compensation and Governance Committee of the Board of Directors each receive an additional $10,000 annual retainer fee. 
The Directors can elect to receive some or all of the $75,000 portion of their annual retainer fees and the additional $10,000 annual retainer fee, if applicable, in shares of the Company’s Common Stock.  The additional $40,000 of annual retainer fees shall be paid in shares of the Company’s Common Stock.  Effective October 20, 2016, the Company adopted a Non-Employee Directors Stock Compensation Deferral Plan, which allows Non-Employee Directors to elect to defer all, or a portion of, their stock retainer fees until termination of service from the Board.  Shares of Common Stock will be issued either under the Company’s 2014 Stock Option and Incentive Plan or the Non-Employee Directors Stock Compensation Deferral Plan.  Directors are also reimbursed for reasonable travel expenses incurred in connection with Board and Committee meeting attendance.
Donald D. Charron, Chairman of the Board and Chief Executive Officer, is a Director and also an employee of the Company but does not receive compensation for his service as a Director.
Named Executive Officer Compensation
Base Pay
Periodically, the Compensation and Governance Committee of the Board of Directors reviews and approves the salaries that are paid to the Company’s executive officers.  The following are the current annualized base salaries for the Company’s Named Executive Officers:
	
				
	Donald D. Charron, Chairman of the Board, Chief Executive Officer
	$
	675,552
	

	John H. Kahle, Vice President, General Counsel, Chief Compliance Officer, Secretary
	$
	397,800
	

	Steven T. Korn, Vice President, North American Operations
	$
	307,607
	

	Michael K. Sergesketter, Vice President, Chief Financial Officer
	$
	303,765
	

	Christopher J. Thyen, Vice President, Business Development
	$
	287,706
	

Cash Incentive Compensation
Each of the Named Executive Officers was eligible to participate in the Company’s 2014 Profit Sharing Incentive Bonus Plan (the “Plan”) during fiscal year 2017.  Under the Plan, cash incentives are accrued annually and paid in five installments over the succeeding fiscal year.  Except for provisions relating to retirement, death, permanent disability, and certain other circumstances described in a participant’s employment agreement, participants must be actively employed on each payment date to be eligible to receive any unpaid cash incentive installment.  The total amount of cash incentives accrued and authorized to be paid to the Named Executive Officers based on fiscal year 2017 results is listed below.  The Named Executive Officers received an installment of 50% of the payment in August 2017, and the remaining portion will be paid in equal installments of 12.5% each in September 2017, January 2018, April 2018, and June 2018.
	
				
	Donald D. Charron, Chairman of the Board, Chief Executive Officer
	$
	443,717
	

	John H. Kahle, Vice President, General Counsel, Chief Compliance Officer, Secretary
	$
	266,526
	

	Steven T. Korn, Vice President, North American Operations
	$
	201,720
	

	Michael K. Sergesketter, Vice President, Chief Financial Officer
	$
	195,710
	

	Christopher J. Thyen, Vice President, Business Development
	$
	186,775
	

Stock Compensation
The Named Executive Officers may also receive a variety of stock incentive benefits under the Company’s 2014 Stock Option and Incentive Plan consisting of: incentive stock options, stock appreciation rights, restricted shares, unrestricted shares, restricted share units, or performance shares and performance units.
The following table summarizes the long-term performance shares (“LTPS”) issued in the Company’s Common Stock during August 2017 to the Company’s Named Executive Officers pursuant to their fiscal year 2017 performance share awards:
	
				
	 
	 
	

LTPS Grant
(Shares Issued) (1)

	Donald D. Charron, Chairman of the Board, Chief Executive Officer
	 
	67,230
	

	John H. Kahle, Vice President, General Counsel, Chief Compliance Officer, Secretary
	 
	33,414
	

	Steven T. Korn, Vice President, North American Operations
	 
	14,084
	

	Michael K. Sergesketter, Vice President, Chief Financial Officer
	 
	13,578
	

	Christopher J. Thyen, Vice President, Business Development
	 
	13,393
	

	 
	 
	 

	(1) Shares have not been reduced by the number of shares withheld to satisfy tax withholding obligations.

During August 2017, the Compensation and Governance Committee awarded LTPS grants for fiscal year 2018 to key employees, including the Named Executive Officers, under the Company’s 2014 Stock Option and Incentive Plan.  One-third (1/3) of the August 2017 LTPS awards will vest annually over the succeeding three-year period.
The following table summarizes the maximum number of performance shares granted in August 2017 to the Company’s Named Executive Officers for fiscal year 2018: 
	
				
	 
	 
	LTPS Award
 (number of shares)

	Donald D. Charron, Chairman of the Board, Chief Executive Officer
	 
	74,351
	

	John H. Kahle, Vice President, General Counsel, Chief Compliance Officer, Secretary
	 
	26,802
	

	Steven T. Korn, Vice President, North American Operations
	 
	15,493
	

	Michael K. Sergesketter, Vice President, Chief Financial Officer
	 
	14,948
	

	Christopher J. Thyen, Vice President, Business Development
	 
	14,590
	

The number of shares to be issued to each participant is based upon a combination of the bonus percentage attainment calculated under the Company’s profit sharing incentive bonus plan, adjusted to a three-year average bonus percentage, and a growth attainment component, which is the Company’s growth in sales revenue based on comparison of its three-year compounded annual growth rate (“CAGR”) with the Electronics Manufacturing Services Industry’s three-year CAGR.
Retirement Plans
The Named Executive Officers participate in a defined contribution, participant-directed retirement plan that all domestic employees are eligible to participate in (the “Retirement Plan”).  The Retirement Plan provides for voluntary employee contributions as well as a discretionary Company contribution which is determined annually by the Compensation and Governance Committee of the Board of Directors.  Each eligible employee’s Company contribution is defined as a percent of eligible compensation, the percent being identical for all eligible employees, including Named Executive Officers.  Participant contributions are fully vested immediately, and Company contributions are fully vested after five years of participation.  All Named Executive Officers are fully vested.  The Retirement Plan is fully funded.  For those eligible employees who, under the 1986 Tax Reform Act, are deemed to be highly compensated, their individual Company contribution under the Retirement Plan is reduced.  For employees who are eligible, including all Named Executive Officers, there is a nonqualified, supplemental employee retirement plan (“SERP”) in which the Company contributes to the account of each individual an amount equal to the reduction in the contribution under the Retirement Plan arising from the provisions of the 1986 Tax Reform Act.  The SERP investment is primarily composed of employee contributions.Exhibit
10.2

 

HELIX
TCS, INC.

SERIES
B PREFERRED STOCK PURCHASE AGREEMENT

 

This
Series B Preferred Stock Purchase Agreement (this
“Agreement”) is made and entered into as of August 25, 2017, by and among (i) Helix
TCS, Inc., a Delaware corporation (the “Company”), and (ii) RSF4, LLC, a Delaware limited liability
company (the “Purchaser”).

 

Witnesseth

 

Whereas,
the Company has authorized a series of preferred stock in its Series B Certificate of Designation (as defined below) designated
as the “Series B Preferred Stock”, and on May 17, 2017, the Company, the Purchaser and Helix Opportunities, LLC entered
into a series of transactions contemplated by that certain Series B Preferred Stock Purchase Agreement (the “May 2017
SPA”);

 

Whereas,
the Company has authorized the sale and issuance of the value of the Company’s Series B Preferred Stock (the “Series
B Preferred Shares”) which are to be sold at the Closing (as defined in Section 2.1);

 

Whereas,
the Purchaser desires to purchase the Series B Preferred Shares on the terms and conditions set forth herein; and

 

Whereas,
the Company desires to issue and sell the Series B Preferred Shares to the Purchaser on the terms and conditions set forth herein.

 

Agreement

 

Now,
Therefore, in consideration of the foregoing
recitals and the mutual promises, representations, warranties, and covenants hereinafter set forth and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.
AGREEMENT TO SELL AND PURCHASE

 

1.1
Authorization of Series B Preferred Shares.
The Company has authorized the sale and issuance to the Purchaser of the Series B Preferred Shares. The Series B Preferred Shares
have the rights, preferences, privileges and restrictions set forth in the Charter, including that certain Certificate of Designations,
Preferences and Rights of Series B Preferred Stock in the form attached to the May 2017 SPA (the “Series B Certificate
of Designation”).

 

1.2
Sale and Purchase. The Company hereby agrees to issue and sell to the Purchaser
and, subject to and in reliance upon the representations, warranties, covenants, terms and conditions hereof, at the Closing,
the Purchaser agrees to purchase, from the Company, 369,756 Series B Preferred Shares (the “Purchased Series B Shares”)
in exchange for an aggregate cash payment equal to $120,000.00 (i.e., a per share price equal to $0.3245 (the “Per
Share Purchase Price”)).

 

    	 	1	 

     

    

 

2.
CLOSING, DELIVERY AND PAYMENT

 

2.1
Closing.

 

(a)
Closing. The sale and purchase of the Series B Preferred Shares shall occur on the date hereof (the “Closing”).

 

(b)
Rights to Purchase Pursuant to Subsequent Closing under May 2017 SPA. This purchase of Series B Preferred Shares shall
be considered a Subsequent Closing as that term is defined in the Series B Preferred Stock Purchase Agreement consummated by the
Parties on May 17, 2017 (the May Agreement”) and shall be counted against the Maximum Amount as that term
is also defined in the May Agreement.

 

2.2
Use of Proceeds. The Company covenants and
agrees to use the proceeds from the sale of the Series B Preferred Shares for working capital purposes.

 

2.3 Payment.
The Purchaser shall pay for the Series B Preferred Shares by wire transfer in accordance with instructions provided by the Company
in an amount equal to the Per Share Purchase Price multiplied by the number of the Series B Preferred Shares purchased.

 

2.4 Delivery.
At the Closing, subject to the terms and conditions
hereof and upon payment of the purchase price therefor, the Company will deliver to the Purchaser a certificate, duly signed by
an authorized agent of the Company, representing the Purchased Series B Shares.

 

3.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

Except
as set forth on a Schedule of Exceptions attached hereto (the “Schedule of Exceptions”), the Company,
on behalf of itself and each member of the Company Group, hereby represents and warrants to the Purchaser as of the date of this
Agreement as set forth below. For purposes of this Section 3, the phrase “to the Company’s knowledge” means
the actual knowledge of the executive officers of the Company.

 

3.1
Organization, Good Standing and Qualification.
The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware.
The Company has all requisite corporate power and authority and any government consents and approvals to (i) own and operate its
properties and assets, (ii) execute and deliver this Agreement, (iii) issue and sell the Series B Preferred Shares, (iv) carry
out the provisions of this Agreement, the Series B Financing Agreements (as such term is defined in the May 2017 SPA) and the
Charter and (v) carry on its business as presently conducted. The Company is duly qualified and is authorized to do business and
is in good standing as a foreign corporation in all jurisdictions in which the nature of its activities and of its properties
(both owned and leased) makes such qualification necessary, except for those jurisdictions in which failure to do so would not
have a material adverse effect on the assets, liabilities, financial condition, prospects or operations of the Company. For the
purposes of this Agreement, the Company’s original Certificate of Incorporation filed with the Secretary of the State of
Delaware on March 13, 2014 (the “Original Certificate”), as (i) amended on May 6, 2014 (in order to
correct a misspelling), (ii) further amended on May 6, 2014, (iii) amended on October 14, 2015, (iv) amended on December 28, 2015
pursuant to an amendment which included the Certificate of Designation of Rights and Privileges of Class A Preferred Convertible
Super Majority Voting Stock (the “Original Series A Certificate of Designation”), and (v) further amended
on May 15, 2017 pursuant to an amendment which included the Series B Certificate of Designation (the amendments described in the
foregoing clauses (i)-(v), collectively, the “Charter Amendments”, and the Original Certificate and
the Amendments are together, collectively referred to herein as the “Charter”.

 

    	 	2	 

     

    

 

3.2
Capitalization; Voting Rights.

 

(a) The
authorized capital stock of the Company, immediately prior to the Closing consists of (i) 200,000,000 shares of common stock,
par value $0.001 per share, 28,644,522 shares of which are issued and outstanding (the “Common Stock”),
and (ii) 20,000,000 shares of Preferred Stock, par value $0.001 per share, (A) 1,000,000 of which are designated “Series A
Preferred Stock” in the Charter, as may be amended from time to time in accordance with this Agreement (the “Series
A Preferred Stock”), all of which are issued and outstanding immediately prior to the Closing; and (B) 13,000,000
of which are designated “Series B Preferred Stock”, 8,998,084 of which are issued and outstanding immediately prior
to the Closing. Attached as Schedule 3.2(a) sets forth the capitalization of the Company immediately prior to the
Closing.

 

(b)
Other than (i) rights to purchase additional shares of the Common Stock vested in those persons and entities and determined
as described in Schedule 3.2(b) attached hereto, and (iii) except as may otherwise be granted pursuant to this Agreement,
the May 2017 SPA and any agreement related thereto (collectively the “Series B Financing Agreements”) , there are
no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal), proxy or stockholder
agreements, or agreements of any kind, including agreements contingent on the occurrence of possible future events, for the purchase
or acquisition from the Company of any of its securities.

 

(c)
The rights, preferences, privileges and restrictions applicable to the Series B Preferred Shares are as stated in the Series
B Certificate of Designation. When issued in compliance with the provisions of this Agreement and the Charter, the Series B Preferred
Shares will be validly issued, fully paid and nonassessable, and will be free of any liens or encumbrances other than liens and
encumbrances created by Purchaser; provided, however, that the Series B Preferred Shares may be subject to restrictions on transfer
under the Series B Financing Agreements, and state and/or federal securities laws as set forth herein or as otherwise required
by such laws at the time a transfer is proposed.

 

(d)
Except as set forth in Schedule 3.2(d) attached hereto, no stock plan, stock purchase, stock option or other
agreement or understanding between the Company and any holder of any equity securities or rights to purchase equity securities
provides for mandatory acceleration or other changes in the vesting provisions or other terms of such agreement or understanding
as the result of (i) termination of employment (whether actual or constructive); (ii) any merger, consolidated sale of stock or
assets, change in control or any other transaction(s) by the Company; (iii) the transactions contemplated hereby or (iv) the occurrence
of any other event or combination of events.

 

    	 	3	 

     

    

 

3.3
Authorization; Binding Obligations.

 

(a)
All corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization
of this Agreement, the performance of all obligations of the Company hereunder at the Closing, the authorization, sale, issuance
and delivery of the Series B Preferred Shares pursuant hereto.

 

(b)
This Agreement, when executed and delivered by the Company, will (assuming the due authorization, execution and delivery hereof
by the Purchaser and other parties thereto) be legal, valid and binding obligations of the Company enforceable in accordance with
their respective terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws
of general application affecting enforcement of creditors’ rights, (b) general principles of equity that restrict the
availability of equitable remedies, and (c) to the extent that the enforceability of the indemnification provisions in the
Series B Financing Agreements may be limited by applicable laws.

 

3.4
No Insolvency. No insolvency proceeding of any character, including, without
limitation, bankruptcy, receivership, reorganization, composition or arrangement with creditors, voluntary or involuntary, affecting
the Company or any of its assets or properties, is pending or, to the Company's knowledge, threatened. Neither the Company, nor
any of its subsidiaries (collectively, with the Company, the “Company Group”), has taken any action
in contemplation of, or that would constitute the basis for, the institution of any such insolvency proceedings.

 

3.5
Litigation. Other than the two
lawsuits by three former employees previously disclosed by the Company, there is no (a) action, suit, proceeding or investigation
pending or, to the Company’s knowledge, currently threatened against any member of the Company Group before or by any Federal,
state, municipal or other governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign,
(b) arbitration proceeding relating to any member of the Company Group pending or (c) governmental inquiry pending or, to
the Company’s knowledge, currently threatened against any member of the Company Group (including without limitation any
inquiry as to the qualification of the Company to hold or receive any license or permit), nor is the Company aware that there
is any basis for any of the foregoing.

 

3.6
Tax Returns and Payments. The
Company has timely filed all tax returns and reports as required by federal, state and local law. These returns and reports are
true and correct in all material respects. The Company has paid all taxes and other assessments due, except those contested by
it in good faith. The provision for taxes of the Company as shown in the Financial Statements is adequate for taxes due or accrued
as of the date thereof. The Company has elected pursuant to the Internal Revenue Code of 1986, as amended (the “Code”),
to be treated as a corporation. During the past three (3) years, the Company has not had any tax deficiency proposed or assessed
against it and has not executed any waiver of any statute of limitations on the assessment or collection of any tax or governmental
charge. During the past three (3) years, none of the Company’s federal income tax returns and none of its state income or
franchise tax or sales or use tax returns has ever been audited by governmental authorities. The Company has withheld or collected
from each payment made to each of its employees the amount of all taxes, including, but not limited to, federal income taxes,
Federal Insurance Contribution Act taxes and Federal Unemployment Tax Act taxes required to be withheld or collected therefrom,
and has paid the same to the proper tax receiving officers or authorized depositaries.

 

    	 	4	 

     

    

 

3.7
Disclosure. The Company has made available to the Purchaser all the information
reasonably available to the Company and its subsidiaries that the Purchaser have requested for deciding whether to acquire the
Purchased Series B Shares. No representation or warranty of the Company contained in this Agreement, as qualified by the Schedule
of Exceptions, and no certificate or other information furnished or to be furnished to Purchaser at the Closing contains any untrue
statement of a material fact or omits to state a material fact necessary in order to make the statements contained herein or therein
not misleading in light of the circumstances under which they were made.

 

4.
REPRESENTATIONS AND WARRANTIES OF THE
PURCHASER.

 

Purchaser
hereby represents and warrants to the Company as follows (such representations and warranties do not lessen or obviate the representations
and warranties of the Company set forth in this Agreement):

 

4.1
Requisite Power and Authority.
Such Purchaser has all necessary power and authority under all applicable provisions of law to execute and deliver this Agreement
and to carry out its provisions. All action on such Purchaser’s part required for the lawful execution and delivery of this
Agreement have been or will be effectively taken prior to the Closing. Upon its execution and delivery, this Agreement will be
valid and binding obligations of such Purchaser, enforceable in accordance with its terms, except (a) as limited by applicable
bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’
rights, and (b) as limited by general principles of equity that restrict the availability of equitable remedies.

 

4.2
Investment Representations. Such
Purchaser understands that none of the Purchased Series B Shares have been registered under the Securities Act. Such Purchaser
also understands that the Series B Preferred Shares are being offered and sold pursuant to an exemption from registration contained
in the Securities Act based in part upon such Purchaser’s representations contained in the Agreement. Such Purchaser hereby
represents and warrants as follows:

 

(a)
Purchaser Bears Economic Risk. Such Purchaser has substantial experience in evaluating and investing in private placement
transactions of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its
investment in the Company and has the capacity to protect its own interests. Such Purchaser must bear the economic risk of this
investment indefinitely unless the Purchased Series B Shares are registered pursuant to the Securities Act, or an exemption from
registration is available. Such Purchaser understands that the Company has no present intention of registering the Purchased Series
B Shares or any shares of the Common Stock. Such Purchaser also understands that there is no assurance that any exemption from
registration under the Securities Act will be available and that, even if available, such exemption may not allow such Purchaser
to transfer all or any portion of the Purchased Series B Shares under the circumstances, in the amounts or at the times that such
Purchaser might propose or desire.

 

    	 	5	 

     

    

 

(b)
Acquisition for Own Account. Such Purchaser is acquiring the Purchased Series B Shares for such Purchaser’s own account
for investment only, and not with a view to distribution, assignment or resale of the Purchased Series B Shares to others or to
fractionalization of the Purchased Series B Shares in whole or in part, in each case, in violation of the Securities Act.

 

(c)
Purchaser Can Protect Its Interest. Such Purchaser represents that by reason of its, or of its management’s, business
or financial experience, such Purchaser has the capacity to protect its own interests in connection with the transactions contemplated
in this Agreement. Further, such Purchaser is aware of no publication of any advertisement in connection with the transactions
contemplated in the Agreement.

 

(d)
Accredited Investor. Such Purchaser represents and warrants that it is an “accredited investor” within the meaning
of Rule 501 of Regulation D, as promulgated under the Securities Act. Purchaser represents and warrants that, to the best of such
Purchaser’s knowledge (after due inquiry), each equity owner of such Purchaser is also an “accredited investor”
within the meaning of Regulation D, as promulgated under the Securities Act.

 

(e)
Rule 144. Such Purchaser acknowledges and agrees that in addition to any requirements under state securities laws, the Series
B Preferred Shares are “restricted securities” as defined in Rule 144 promulgated under the Securities Act as in effect
from time to time (“Rule 144”) and must be held indefinitely unless they are subsequently registered
under the Securities Act or an exemption from such registration is available. Such Purchaser has been advised or is aware of the
provisions of Rule 144, which permits limited resale of shares purchased in a private placement subject to the satisfaction of
certain conditions, including, among other things, the availability of certain current public information about the Company, the
resale occurring following the required holding period under Rule 144, and the number of shares being sold during any three-month
period not exceeding specified limitations. Such Purchaser has been further advised that the Company has no present intention
of satisfying the current public information requirements of Rule 144, and as a result such Purchaser will be able to rely on
Rule 144 only under the limited circumstances described in that rule.

 

(f)
Residence. Purchaser is a resident of the state of New York.

 

(g)
Foreign Investors. If such Purchaser is not a United States person (as defined by Section 7701(a)(30) of the Code), such Purchaser
hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any
invitation to subscribe for the Purchased Series B Shares or any use of this Agreement, including (i) the legal requirements within
its jurisdiction for the purchase of the Purchased Series B Shares, (ii) any foreign exchange restrictions applicable to such
purchase, (iii) any government or other consents that may need to be obtained, and (iv) the income tax and other tax consequences,
if any, that may be relevant to the purchase, holding, redemption, sale or transfer of the Purchased Series B Shares. Such Purchaser’s
subscription and payment for and continued beneficial ownership of the Purchased Series B Shares will not violate any applicable
securities or other laws of such Purchaser’s jurisdiction.

 

    	 	6	 

     

    

 

(h)
No General Solicitation. To the knowledge of such Purchaser, the Series B Preferred Shares have not been offered to such Purchaser
by any form of general solicitation or general advertising, including, without limitation, (A) any advertisement, article, notice
or other communication published in any newspaper, magazine or similar media, or broadcast over television or radio, or (B) any
seminar or meeting whose attendees (including the Purchaser) have been invited by any general solicitation or general advertising.

 

4.3
Transfer Restrictions. Such Purchaser
acknowledges and agrees that the Purchased Series B Shares are subject to restrictions on transfer as set forth in the Series
B Financing Agreements.

 

4.4
Not a Bad Actor. Neither Purchaser nor any of its affiliates that could stand
as beneficial owner of the Securities purchased hereunder, is subject to any of the “Bad Actor” disqualifications
described in Securities Act Rule 506(d)(1) subsections (i) through (viii).

 

5.
MISCELLANEOUS.

 

5.1
Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement
shall be governed by and construed in accordance with the General Corporation Law of the State of Delaware, without regard to
its principles of conflicts of laws. Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the courts
of the State of Delaware located in Wilmington, Delaware and the United States District Court for the District of Delaware for
the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated
hereby.  Service of process in connection with any such suit, action or proceeding may be served on each party hereto anywhere
in the world by the same methods as are specified for the giving of notices under this Agreement.  Each of the parties hereto
irrevocably consents to the jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in
such court.  Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding
brought in such courts and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has
been brought in an inconvenient forum.  EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION
WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

 

5.2
Successors and Assigns. Except
as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors,
assigns, heirs, executors and administrators of the parties hereto and shall inure to the benefit of and be enforceable by each
person who shall be a holder of the Series B Preferred Shares from time to time.

 

5.3
Entire Agreement. This Agreement
together with the Series Financing Agreements, subject to the waivers provided herein, the exhibits and schedules hereto and thereto,
and the other documents delivered pursuant hereto and thereto constitute the full and entire understanding and agreement between
the parties with regard to the subjects hereof and thereof and no party shall be liable or bound to any other in any manner by
any representations, warranties, covenants and agreements except as specifically set forth herein and therein.

 

    	 	7	 

     

    

 

5.4
Severability. In case any provision
of the Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions
shall not in any way be affected or impaired thereby.

 

5.5
Amendment and Waiver.

 

(a)
This Agreement may be amended or modified only upon the written consent of the Company and holders of at least a majority
of the Series B Preferred Shares then outstanding (treated as if converted into which the Series B Preferred Shares have been
converted that have not been sold to the public). Any such amendment or modification effected in accordance with this Section
5.5(a) shall be binding on all parties hereto, even if they do not execute such consent.

 

(b)
Subject to Section 5.5(c) below, any party hereto may waive compliance with any agreements, covenants or conditions for the
benefit of such party contained herein. Any agreement on the part of a party hereto to any such waiver shall be valid only if
set forth in an instrument in writing signed on behalf of such party.

 

(c)
  The obligations of the Company and the rights of the holders of the Series B Preferred Shares under the Agreement may
be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent
of the holders of at least a majority of the Series B Preferred Shares then outstanding (treated as if converted into which the
Series B Preferred Shares have been converted that have not been sold to the public). Any such waiver effected in accordance with
this Section 5.5(c) shall be binding on all parties hereto, even if they do not execute such consent.

 

(d)
The Purchaser expressly waives and acknowledges the satisfaction of any and all terms and conditions contained in the Series
B Financing Agreements as it relates to the Closing under this Agreement, including the terms and conditions set forth in Section
2.1 of the May 2017 SPA; provided that, for the avoidance of doubt, such waiver does not limit or impair Purchaser’s rights
under Section 2.1(b) in a subsequently closing following the Closing.

 

5.6
Delays or Omissions. No delay or omission to exercise any right, power or remedy
accruing to any party, upon any breach, default or noncompliance by another party under this Agreement, or the Charter, shall
impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance,
or any acquiescence therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed
that any waiver, permit, consent or approval of any kind or character on Purchaser’s part of any breach, default or noncompliance
under this Agreement, or under the Charter or any waiver on such party’s part of any provisions or conditions of the Agreement
or the Charter must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies,
either under this Agreement, the Charter, by law, or otherwise afforded to any party, shall be cumulative and not alternative.

 

    	 	8	 

     

    

 

5.7
Notices. All notices required
or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party
to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not,
then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery,
with written verification of receipt.

 

5.8
Expenses. The Company and the
Purchaser shall each pay their own expenses in connection with the transactions contemplated by this Agreement; provided,
however that the Company shall pay the reasonably documented fees and expenses of Purchaser in an amount not to exceed
$10,000.

 

5.9
Attorneys’ Fees. In the
event that any suit or action is instituted to enforce any provision in this Agreement, the prevailing party in such dispute shall
be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such prevailing party under
or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys and accountants,
which shall include, without limitation, all fees, costs and expenses of appeals.

 

5.10
Titles and Subtitles. The titles
of the sections and subsections of the Agreement are for convenience of reference only and are not to be considered in construing
this Agreement.

 

5.11
Pronouns. All pronouns contained
herein, and any variations thereof, shall be deemed to refer to the masculine, feminine or neutral, singular or plural, as to
the identity of the parties hereto may require.

 

5.12
Counterparts. This Agreement may be executed in any number of counterparts,
each of which shall be an original, but all of which together shall constitute one instrument. This Agreement may be executed
by facsimile signatures or via .pdf signature.

  

Signatures
on the Following Page

 

    	 	9	 

     

    

 

This
Series B Preferred Stock Purchase Agreement is hereby executed as of the
date first above written.

 

	The
    Company:	 
	 	 	 
	Helix
    Tcs, Inc.	 
	 	 	 
	By:	 	 
	Name:	Zachary
    L. Venegas	 
	Title:	Chief
    Executive Officer	 
	 	 	 
	The
    Purchaser:	 
	 	 	 
	RSF4,
    LLC	 
	 	 	 
	By:	Rose
    Capital Fund I GP, LLC, its Manager	 
	 	 	 
	By: 	 	 
	 	Name:
    Andrew Schweibold	 
	 	Title:
    Principal	 
	 	 	 
	By: 	 	 
	 	Name:
    Jonathan Rosenthal	 
	 	Title:    Principal	 

 

 

 

 

 

 

 

 

 

 

 

 

 

Helix
TCS, Inc. Series B Preferred Stock Purchase Agreement 

Signature
Page

 

     

     

    

 

Schedule
3.2(a) 

Capitalization

 

See
attached Capitalization Table

 

Schedule
3.2(b)

Purchase
Rights

 

	Paul
    Hodges	1,920,000
    warrants @$0.16 per share
	Red
    Diamond, LLC	25,000
    cashless warrants @ $1.00 per share
	Red
    Diamond, LLC	150,000
    cashless warrants @ $1.00 per share
	Andrew
    Feldschreiber	231,098
    warrants @ $0.3245 per share
	Evan
    Schwartzberg	134,036
    warrants @ $0.3245 per share
	Mathew
    Van Alstyne	97,061
    warrants @ $0.3245 per share
	Former
    Security Grade Shareholders	414,854
    warrants @ $0.001 per share

 

The
convertible notes described in Schedule 3.2(a) above are incorporated herein by reference

 

Schedule
3.2(d) 

Acceleration
of Rights

 

Red
Diamond Warrants

Former
Security Grade Shareholders Warrants

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]